Emerging roles of long non-coding RNA in depression

Area of Science:

• Neuroscience
• Genetics
• Genomics
• Psychiatry

Background:

• Depression affects over 340 million globally, with unclear mechanisms and problematic treatments.
• Existing antidepressants have limitations, including dependence and side effects.
• Long non-coding RNAs (lncRNAs) are emerging as key modulators in depression.

Purpose of the Study:

• To explore the role of lncRNAs in the pathogenesis, diagnosis, and therapy of depression.
• To investigate lncRNAs as potential diagnostic biomarkers for depression and related mental illnesses.
• To establish a comprehensive network for understanding lncRNA's role in depression.

Main Methods:

• Review of neuroscience, genetics, and genomics literature on lncRNAs and depression.
• Analysis of genome-wide association studies and molecular biology experiments.
• Bioinformatics analysis to construct a lncRNA-miRNA-mRNA-pathway-drug network for depression.

Main Results:

• LncRNAs regulate depression through pathways involving neurotransmitters, neurotrophic factors, and neurogenesis.
• LncRNAs show potential as biomarkers for differentiating depression from other psychiatric disorders.
• A detailed network analysis provides insights into lncRNA-mediated depression mechanisms.

Conclusions:

• LncRNAs are implicated in the development, diagnosis, and treatment of depression.
• Further research into lncRNAs could lead to novel therapeutic strategies and diagnostic tools.
• Understanding lncRNA functions is crucial for advancing epigenetic research in clinical depression.